Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (28889)	6/15/1999 9:13:00 AM
From: Arthur Radley	Read Replies (1) of 32384

From the news release yesterday..." Ligand has also studied Targretin for the treatment of patients with cutaneous T-cell lymphoma, for which Ligand expects to file a new drug application for Targretin capsules in the first half of 1999, as well as for advanced lung cancer, ovarian cancer, head and neck cancer, Kaposi's sarcoma, psoriasis and actinic keratoses. " If this statement is true, then doesn't this mean that they will file the NDA within the next TWO weeks?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next